Search results :


More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: L02BA02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3
Hot flush postmarketing, 30% - 35% x x x
Sweating postmarketing, 17% - 20% x x x
Nausea postmarketing, 14% - 15% x x x
Vaginal discharge postmarketing, 13% - 16% x
Dry eye 7.44% - 9.05% x
Dizziness 7% - 9% x x x
Cataract 2.49% - 9.95% x
Oedema 5% x x x
Vomiting 2% - 4% x x x
Vaginal haemorrhage 2% - 4% x x
Hypercalcaemia 0.637% - 2.79% x x x
Diplopia 1.4% x
Abnormal vision 1.4% x
Keratopathy 0.93% - 1.81% x
Thrombosis 0.465% - 1.99% x
Arrhythmia 0.498% - 1.4% x
Thrombophlebitis 0.637% - 1.87% x x
Cardiac failure 0.465% - 1.49% x
Myocardial infarction 0.498% - 1.4% x
Glaucoma 0.498% - 1.36% x
Pulmonary embolism 0.498% - 1.81% x x
Angina pectoris 0.467% - 0.995% x
Alopecia x x x
Anorexia x x
Arthritis x
Asthenia x x
Ataxia x
Back pain x
Mental disorder x
Breast disorder x
Chest pain x
Constipation x x x
Corneal opacity x x x
Cyst x
Dermatitis x x
Dyspnoea x x x
Endometrial hyperplasia x
Rash x
Eye disorder x
Fatigue x x x
Gastrointestinal disorder x x
Headache x x
Hepatitis toxic x
Jaundice x x x
Lethargy x
Leukopenia x
Leukorrhea x x
Liver disorder x
Mediastinal disorder x
Metabolic disorder x
Nervous system disorder x
Pain x
Paresis x x
Neuropathy peripheral x
Polyp x
Pruritus x x x
Thrombocytopenia x
Tremor x x
Uterine haemorrhage x
Angiopathy x
Vertigo x x x
Disorder sight x
Weight increased x x
Mood swings x
Deep vein thrombosis x
Liver function test abnormal x
Skin discolouration x x
Uterine polyp x
Malnutrition x
Unspecified disorder of skin and subcutaneous tissue x
Hepatobiliary disease x
Vision blurred x
Rigors x
Stiffness x
Endometrial cancer x
Coordination abnormal x
Ear and labyrinth disorders x
Thromboembolic event x x
Endometrial hypertrophy x x
Oestrogenic effect x
Insomnia x x
Appetite absent x


Information about indications was extracted from the indications and usage sections of the labels.

toremifene / toremifene

Side effects:44


Side effects:46
Source:FDA Structured Product Label

Color scheme:


    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    no frequency information
    not found on label